Stocks › CMRX
CMRX
CMRX·USD
—
No end-of-day price on record
CMRX
CMRX
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CMRXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CMRX by members of U.S. Congress · 2 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 James B. RenacciHouse · R · OH |
CMRXCMRX · Stock |
Sale $1,001 - $15,000 |
Dec 21, 2015 | Dec 9, 2015 | Filing ↗ |
| James B. RenacciHouse · R · OH |
CMRXCMRX · Stock |
Purchase $15,001 - $50,000 |
Feb 10, 2015 | Jan 28, 2015 | Filing ↗ |
Whale Activity
Institutional 13F positions
No 13F positions in CMRX among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CMRX insiders, by quarter · Form 4
Recent Insider Transactions
407 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Sherman Michael A.Chief Executive Officer · Director | Disposition to issuer | −233.4K | $8.55 | $2.0M | Apr 21, 2025 | Form 4 ↗ |
| Sherman Michael A.Chief Executive Officer · Director | Disposition to issuer | −103.0K | $8.55 | $881K | Apr 21, 2025 | Form 4 ↗ |
| Sherman Michael A.Chief Executive Officer · Director | Disposition to issuer | −87.0K | $8.55 | $744K | Apr 21, 2025 | Form 4 ↗ |
| Riga Thomas JCOO and CCO | Disposition to issuer | −60.8K | $8.55 | $520K | Apr 21, 2025 | Form 4 ↗ |
| MIDDLETON FRED ADirector | Disposition to issuer | −207.5K | $8.55 | $1.8M | Apr 21, 2025 | Form 4 ↗ |
| MIDDLETON FRED ADirector | Disposition to issuer | −531.9K | $8.55 | $4.5M | Apr 21, 2025 | Form 4 ↗ |
| MIDDLETON FRED ADirector | Disposition to issuer | −2.8M | $8.55 | $23.7M | Apr 21, 2025 | Form 4 ↗ |
| MIDDLETON FRED ADirector | Disposition to issuer | −60.0K | $8.55 | $513K | Apr 21, 2025 | Form 4 ↗ |
| MIDDLETON FRED ADirector | Disposition to issuer | −40.0K | $8.55 | $342K | Apr 21, 2025 | Form 4 ↗ |
| Meyer Robert J.Director | Disposition to issuer | −35.1K | $8.55 | $301K | Apr 21, 2025 | Form 4 ↗ |
| Melemed Allen S.CHIEF MEDICAL OFFICER | Disposition to issuer | −173.9K | $8.55 | $1.5M | Apr 21, 2025 | Form 4 ↗ |
| LaSpaluto MichelleCHIEF FINANCIAL OFFICER | Disposition to issuer | −181.5K | $8.55 | $1.6M | Apr 21, 2025 | Form 4 ↗ |
| Jakeman DavidVP OF FINANCE AND ACCOUNTING | Disposition to issuer | −156.2K | $8.55 | $1.3M | Apr 21, 2025 | Form 4 ↗ |
| DEMSKI MARTHA JDirector | Disposition to issuer | −72.1K | $8.55 | $616K | Apr 21, 2025 | Form 4 ↗ |
| Andriole Michael T.PRESIDENT AND CEO · Director | Disposition to issuer | −630.8K | $8.55 | $5.4M | Apr 21, 2025 | Form 4 ↗ |
| Alrutz Michael AlbertSVP AND GENERAL COUNSEL | Disposition to issuer | −216.7K | $8.55 | $1.9M | Apr 21, 2025 | Form 4 ↗ |
| Melemed Allen S.CHIEF MEDICAL OFFICER | Sale | −3,065 | $4.50 | $14K | Feb 13, 2025 | Form 4 ↗ |
| Andriole Michael T.PRESIDENT AND CEO · Director | Sale | −7,370 | $4.52 | $33K | Feb 13, 2025 | Form 4 ↗ |
| Alrutz Michael AlbertSVP AND GENERAL COUNSEL | Sale | −1,600 | $4.52 | $7K | Feb 13, 2025 | Form 4 ↗ |
| Jakeman DavidVP OF FINANCE AND ACCOUNTING | Sale | −300 | $4.53 | $1K | Feb 13, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CMRX · SEC Form N-PORT
Funds report their holdings by CUSIP, and CMRX could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming CMRX as client
No lobbying filings found naming CMRX as the client.
Government Contracts
Federal awards to CMRX · USAspending
No federal contract awards found for CMRX.
U.S. Patents
Recent USPTO applications naming CMRX
No USPTO patent applications found for CMRX.
Annual Financials
From CMRX's 10-K filings · XBRL
No annual XBRL figures on record for CMRX. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No price history on record for CMRX.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About CMRX
From SEC EDGAR company records
No company profile on record.